RAB5A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.856400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.286600E-01
Normal-vs-Stage2
6.420200E-01
Normal-vs-Stage3
3.241200E-01
Normal-vs-Stage4
1.492020E-01
Stage1-vs-Stage2
7.346200E-01
Stage1-vs-Stage3
1.854010E-01
Stage1-vs-Stage4
9.722000E-02
Stage2-vs-Stage3
1.021980E-01
Stage2-vs-Stage4
6.174100E-02
Stage3-vs-Stage4
2.188300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.067400E-01
Normal-vs-AfricanAmerican
8.534800E-01
Normal-vs-Asian
6.485400E-01
Caucasian-vs-AfricanAmerican
9.080200E-01
Caucasian-vs-Asian
6.567200E-01
AfricanAmerican-vs-Asian
7.321200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.277000E-01
Normal-vs-Female
6.383600E-01
Male-vs-Female
5.852600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.401800E-01
Normal-vs-Age(41-60Yrs)
3.978800E-01
Normal-vs-Age(61-80Yrs)
8.178600E-01
Normal-vs-Age(81-100Yrs)
7.248000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.877200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.890400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.750000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.850090E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.015900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.778200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.924600E-01
Normal-vs-Daily Drinker
9.433400E-01
Normal-vs-Weekly Drinker
8.642000E-01
Normal-vs-Occasional Drinker
3.443400E-01
Normal-vs-Social Drinker
6.213200E-01
Non Drinker-vs-Daily Drinker
6.608000E-01
Non Drinker-vs-Weekly Drinker
9.628400E-01
Non Drinker-vs-Occasional Drinker
1.523400E-01
Non Drinker-vs-Social Drinker
5.345800E-01
Daily Drinker-vs-Weekly Drinker
6.723000E-01
Daily Drinker-vs-Occasional Drinker
7.590100E-02
Daily Drinker-vs-Social Drinker
3.263200E-01
Weekly Drinker-vs-Occasional Drinker
2.027400E-01
Weekly Drinker-vs-Social Drinker
5.938200E-01
Occasional Drinker-vs-Social Drinker
4.651800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.263400E-01
Normal-vs-Grade 2
3.218100E-02
Normal-vs-Grade 3
3.945700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.165800E-02
Grade 1-vs-Grade 3
4.773600E-02
Grade 1-vs-Grade 4
2.263400E-01
Grade 2-vs-Grade 3
5.975400E-01
Grade 2-vs-Grade 4
3.218100E-02
Grade 3-vs-Grade 4
3.945700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.635600E-01
Normal-vs-NonDiabetic
7.274000E-01
Diabetic-vs-NonDiabetic
3.505800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.852000E-01
Normal-vs-NoPancreatitis
7.575400E-01
Pancreatitis-vs-NoPancreatitis
7.287600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.768200E-01
Normal-vs-N1
6.597600E-01
N0-vs-N1
9.125000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.217600E-01
Normal-vs-TP53-NonMutant
9.784200E-01
TP53-Mutant-vs-TP53-NonMutant
8.775800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
